Glycopeptides derived from pancreatic structures, antibodies and applications thereof in diagnostics and therapeutics

Details for Australian Patent Application No. 2005229451 (hide)

Owner Universite de la Mediterranee INSERM (Institut National de la Sante et de la Recherche Medicale)

Inventors Lombardo, Dominique; Panicot-Dubois, Laurence; Bernard, Jean-Paul; Sadoulet, Marie-Odile; Mas, Eric

Agent Davies Collison Cave

Pub. Number AU-B-2005229451

PCT Pub. Number WO2005/095594

Priority 0403378 31.03.04 FR; 0413428 16.12.04 FR

Filing date 30 March 2005

Wipo publication date 13 October 2005

Acceptance publication date 18 March 2010

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C12N 9/20 (2006.01) Enzymes, e.g. ligases (6.)

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

21 September 2006 PCT application entered the National Phase

  PCT publication WO2005/095594 Priority application(s): WO2005/095594

18 March 2010 Application Accepted

  Published as AU-B-2005229451

12 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005229452-Novel pyrrolo (2,3-b)pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors

2005229442-Dark grey soda-lime-silica glass composition which is intended for the production of glazing